[go: up one dir, main page]

BG100456A - Ranitidine and calcium carbonate pharmaceutical product - Google Patents

Ranitidine and calcium carbonate pharmaceutical product

Info

Publication number
BG100456A
BG100456A BG100456A BG10045696A BG100456A BG 100456 A BG100456 A BG 100456A BG 100456 A BG100456 A BG 100456A BG 10045696 A BG10045696 A BG 10045696A BG 100456 A BG100456 A BG 100456A
Authority
BG
Bulgaria
Prior art keywords
calcium carbonate
ranitidine
pharmaceutical product
carbonate pharmaceutical
pharmaceutical composition
Prior art date
Application number
BG100456A
Other languages
Bulgarian (bg)
English (en)
Inventor
Mark Sirgo
Original Assignee
Glaxo Wellcome Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc. filed Critical Glaxo Wellcome Inc.
Publication of BG100456A publication Critical patent/BG100456A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10Carbonates; Bicarbonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BG100456A 1993-09-30 1996-03-27 Ranitidine and calcium carbonate pharmaceutical product BG100456A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12951793A 1993-09-30 1993-09-30
PCT/US1994/011132 WO1995008997A1 (en) 1993-09-30 1994-09-29 Ranitidine and calcium carbonate pharmaceutical combination product

Publications (1)

Publication Number Publication Date
BG100456A true BG100456A (en) 1996-11-29

Family

ID=22440376

Family Applications (1)

Application Number Title Priority Date Filing Date
BG100456A BG100456A (en) 1993-09-30 1996-03-27 Ranitidine and calcium carbonate pharmaceutical product

Country Status (17)

Country Link
EP (1) EP0721338A1 (xx)
JP (1) JPH09503212A (xx)
CN (1) CN1140996A (xx)
AU (1) AU677108B2 (xx)
BG (1) BG100456A (xx)
CA (1) CA2168846A1 (xx)
CZ (1) CZ76996A3 (xx)
HU (1) HUT75061A (xx)
IL (1) IL111094A0 (xx)
NO (1) NO961297L (xx)
NZ (1) NZ274713A (xx)
OA (1) OA10717A (xx)
PL (1) PL316855A1 (xx)
SG (1) SG44715A1 (xx)
SK (1) SK40596A3 (xx)
WO (1) WO1995008997A1 (xx)
ZA (1) ZA947553B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5560701B2 (ja) * 2008-12-26 2014-07-30 ライオン株式会社 ラニチジン含有医薬固形製剤及びラニチジン担持粒子の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1002406A5 (fr) * 1988-09-20 1991-01-29 Glaxo Group Ltd Compositions pharmaceutiques.
WO1992000102A1 (en) * 1990-06-22 1992-01-09 Beecham Group Plc Novel treatment
GB9127150D0 (en) * 1991-12-20 1992-02-19 Smithkline Beecham Plc Novel treatment
US5229137A (en) * 1992-05-06 1993-07-20 Brigham And Women's Hospital, Inc. Methods and pharmaceutical compositions for treating episodic heartburn

Also Published As

Publication number Publication date
NO961297D0 (no) 1996-03-29
ZA947553B (en) 1995-05-26
NZ274713A (en) 1997-10-24
PL316855A1 (en) 1997-02-17
JPH09503212A (ja) 1997-03-31
HU9600810D0 (en) 1996-05-28
HUT75061A (en) 1997-03-28
CA2168846A1 (en) 1995-04-06
EP0721338A1 (en) 1996-07-17
OA10717A (en) 2002-12-09
IL111094A0 (en) 1994-11-28
CN1140996A (zh) 1997-01-22
AU7925394A (en) 1995-04-18
CZ76996A3 (en) 1996-10-16
NO961297L (no) 1996-03-29
WO1995008997A1 (en) 1995-04-06
AU677108B2 (en) 1997-04-10
SK40596A3 (en) 1997-02-05
SG44715A1 (en) 1997-12-19

Similar Documents

Publication Publication Date Title
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
FI922364A0 (fi) Farmaceutiska kompositioner.
FI901102A0 (fi) Farmaceutiska kompositioner.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
EP0695171A1 (en) GONADOTROPINE CONTAINING FREEZER DRIED DROPS
SE9704546D0 (sv) Novel compounds
DE69801369D1 (de) Peptidanaloge des lh-rh, ihre verwendungen und die sie enthaltenden pharmazeutischen zusammensetzungen
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
DE69300913D1 (de) Polymorph Terazosin und pharmazeutische Zusammenstellung.
IT8920486A0 (it) Composizioni farmaceutiche.
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
DE68913531D1 (de) Kalziumhypochloritzusammensetzung.
BG103714A (en) Pararacetamol-containing tablet
ES2177024T3 (es) Empleo de la fanquinoma para el tratamiento de la enfermedaad de alzheimer.
PT1355906E (pt) Derivados de 2h-1-benzopirano processos para a sua preparacao e as suas composicoes farmaceuticas
HN1998000045A (es) Composiciones farmaceuticas
BR9605046B1 (pt) compostos n-(pirimidinl)-benzenossulfonamida e preparação farmacêutica contendo as mesmas.
FI884545A0 (fi) Farmaceutisk komposition, som innehaoller avsvaellande piperidinoalkanolfoereningar.
BG100456A (en) Ranitidine and calcium carbonate pharmaceutical product
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
IT235651Y1 (it) Fermo per evitare la dilatazione di contenitori comprimibili, dopo laloro compressione.
EA200000531A1 (ru) Применение кетолидов для профилактики тромботических артериальных осложнений, связанных с атеросклерозом
DE69521315D1 (de) Hirudin enthaltende pharmazeutische zusammensetzungen